The emerging role of personalized medicine
Our products are unusual. In part because the founding science is relatively new concept in the marketplace. Traditional medicine is approached as a "trial and error" method and is usually directed against the particular symptoms of the patient. Our approach is to look deeper into the underlying causes of their disease and/or medical condition. In so doing, we find that patients can often be grouped according to their genetic background. Such characteristics may reveal a predisposition to metabolic imbalances, enzyme deficiencies or various physiologic triggers that complicate their disease or condition. Pamlab believes that the future of pharmacology will become more personalized according to each patients genetic predisposition rather than a "one-size fits all" approach.
New Product Pipeline
Our Research and Development staff is in continuous review of new pharmaceutical products to be launched or acquired. Our sales force includes both dedicated outside sales representatives as well as multiple inside sales teams. Our sales force gives us a national presence while our inside sales force provides physician support and online education. The resulting infrastructure provides optimum flexibility for both national new product roll-outs as well as specialty or niche product introductions.
To anticipate our future expansion of products and new indications, feel free to peruse our R&D website which lists all active IRB-supervised projects as well as our recently completed clinical studies.